Product Images Eliquis

This is a table with different subgroups of patients comparing the use of Apixaban versus Warfarin in terms of event occurrence. The table shows the number of patients, the percentage per year, the hazard ratio, and the corresponding confidence interval for each subgroup. The subgroups are classified by patient characteristics such as age, weight, stroke or TIA history, and geographic region. The table also shows whether randomization was used and if the patient has diabetes or a certain score on the CHADS scale. The table indicates that Apixaban has better results in terms of event occurrence compared to Warfarin in various subgroups of patients.*

This appears to be a table or chart showing the interaction of certain drugs with P-gp and CYP3A4 inhibitors and inducers. The table shows the fold change in drug PK (pharmacokinetics) and 90% CI (confidence interval) for drugs such as ketoconazole, glarithromycin, diltiazem, naproxen, and rifampin. The table also shows the AUC (area under the curve) and the relative change in comparison to a reference drug.*

This is a population description for PK parameters for various renal and hepatic impairments, age groups, and body weights. The data shows fold change and 90% CI for different parameters relative to the reference, and provides dosing recommendations, including "no dose adjustment" and "dosing recommendation cannot be provided".*

This text appears to be a label for a medication named "APTXABAN" which contains 2.5 MG and has 60 tablets. The label also provides storage instructions to keep the medication at 6870 7 degrees Celsius. The other text "1mc, zes, préduct. 6813-0, tllous" is not clear and cannot be understood.*

This appears to be a label for a medication called "APTXABAN" with a strength of 5mg. The label indicates that the medication should be stored at 68-77 degrees Fahrenheit and includes 60 tablets. No further information is available.*